“genentech” Archives

in
Entry Author Date Location
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M 02/06/19 San Diego
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo 01/18/19 Indiana
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter 01/16/19 National
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Genentech, Adaptive Bio Join Forces on Personalized Cancer Drugs R&D 01/04/19 Seattle
Ligand Inks Deal, Ionis Details Succession Plan, & More SD Biotech 12/21/18 San Diego
With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca 12/18/18 San Diego
Kineta Gets $15M in New Cancer Drug Partnership with Pfizer 12/17/18 Seattle
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics 11/27/18 San Francisco
CEOs and Scientific Founders: Tips for a Long and Successful Marriage 11/13/18 New York
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
Ansun BioPharma Adds Stanley Lewis to C-Suite 10/12/18 San Diego
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom 10/04/18 San Francisco
Another Precision Step for Roche as Ignyta Drug Heads to Regulators 09/24/18 San Francisco
Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies 09/10/18 San Francisco
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
After a High-Speed Decade, Agios CEO David Schenkein to Step Aside 09/04/18 Boston
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future? 08/08/18 San Francisco
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
With Roche Data, Cancer Combos Post First Win Vs. Small Cell Lung Cancer 06/25/18 San Francisco
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine 06/19/18 Boston
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results 05/29/18 San Francisco
Data Could Make Roche Drug a Hemophilia Standard, But for How Long? 05/21/18 San Francisco
Page 1 of 21 next page »